Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
541
Total Claims
$679K
Drug Cost
107
Beneficiaries
$6,342
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
-47%
Opioid rate vs peers
3.3% vs 6.3% avg
-53%
Cost per patient vs peers
$6,342 vs $14K avg
-1%
Brand preference vs peers
14.4% vs 14.6% avg
Opioid Prescribing
3.3%
Opioid Rate
18
Opioid Claims
$359
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 78 claims · $627K
Generic: 463 claims · $51K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Zanubrutinib | 14 | $179K |
| Filgrastim-Aafi | 16 | $14K |
| Abiraterone Acetate | 45 | $5,644 |
| Anastrozole | 44 | $1,197 |
| Letrozole | 64 | $1,180 |
| Imatinib Mesylate | 12 | $643 |
| Dexamethasone | 37 | $469 |
| Prochlorperazine Maleate | 28 | $368 |
| Ondansetron Hcl | 40 | $319 |
| Prednisone | 33 | $230 |
| Gabapentin | 16 | $225 |
Prescribing Profile
11
Unique Drugs
3.0
Anomaly Score
Patient Profile
73
Avg Age
70%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About